Vernalis' Merger

Vernalis raised a round of funding on March 24, 2003. Investors include British Biotech.

Vernalis, formerly known as RiboTargets, is a research and development based bio-pharmaceutical company. The firm has one marketed product, frovatriptan, six product candidates in clinical trials and …

Articles about Vernalis' Merger: